Clinical Report: Could Red-Light Therapy Change Myopia Care?
Overview
Repeated low-level red-light therapy may reduce myopia progression in pediatric patients over 12 months, with treatment effects increasing over time. Significant improvements were noted in spherical equivalent refraction, axial length, and choroidal thickness compared to controls.
Background
Incorporate specific statistics or studies that emphasize the urgency of addressing myopia.
Data Highlights
| Outcome | 12 Months Improvement |
|---|---|
| Spherical Equivalent Refraction | 0.68 diopters |
| Axial Length | -0.30 mm |
| Choroidal Thickness | +27 µm |
Key Findings
- 28 randomized controlled trials with 3,573 pediatric patients were included in the analysis.
- At 12 months, patients with high myopia experienced the greatest benefit, with a 0.90-diopter improvement.
- Short-term structural parameters remained stable, with no severe treatment-related adverse events reported.
- Some patients experienced transient visual disturbances and discomfort, leading to treatment discontinuation.
- Evidence for improvements in spherical equivalent refraction and choroidal thickness was rated as moderate certainty.
Clinical Implications
Clinicians should consider repeated low-level red-light therapy as a potential option for managing myopia in pediatric patients, particularly for those with higher baseline myopia. However, the need for long-term safety data and careful patient selection remains critical.
Conclusion
Repeated low-level red-light therapy appears to be an effective intervention for slowing myopia progression in children, with increasing benefits over time. Further research is necessary to assess long-term safety and efficacy.
Related Resources & Content
- Lee-Yuan Lin et al., Clinical & Experimental Ophthalmology, 2023 -- Efficacy of repeated low-level red-light therapy for myopia management in children and adolescents: a systematic review and meta-analysis
- Hashim Khan, OD, Contact Lens Spectrum, 2023 -- RED LIGHT: A STOP SIGNAL FOR MYOPIA PROGRESSION?
- Maria Liu, OD, PHD, MPH, MBA, FAAO, Optometric Management, 2023 -- CLINICAL: Myopia
- Andrew D. Pucker, OD, MS, FAAO, Optometric Management, 2023 -- Myopia Control Spectacles: Review of the Latest Research
- International Myopia Institute, 2025 -- IMI Interventions for Controlling Myopia Onset and Progression 2025
- Contact Lens Spectrum — Myopia Beyond 2025
- Myopia Beyond 2025
- Safety Evaluation of 4 Red Light Therapy Devices for Myopia
- IMI Interventions for Controlling Myopia Onset and Progression 2025 - Myopia Institute
- Efficacy of repeated low-level red-light therapy for myopia management in children and adolescents: a systematic review and meta-analysis - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
